Cargando…
What to do when the neuropathy worsens after successful heart and liver transplantation in a Glu89Lys Transthyretin Amyloidosis?
Autores principales: | Kuntzer, Thierry, Ochsner, Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642059/ http://dx.doi.org/10.1186/1750-1172-10-S1-P37 |
Ejemplares similares
-
Cardiac involvement and clinical follow up of patients with hereditary transthyretin related amyloidosis associated with Glu89Gln mutation
por: Gospodinova, Mariana, et al.
Publicado: (2015) -
Glu89Gln transthyretin-related amyloidosis in Italy and Bulgaria: does geographic area influence phenotype beyond the shared mutation?
por: Gagliardi, Christian, et al.
Publicado: (2015) -
Is 99mTc-diphosphonate uptake the earliest sign of cardiac amyloidosis development in asymptomatic Glu89Gln transthyretin gene mutation carriers?
por: Minutoli, Fabio, et al.
Publicado: (2015) -
The neuropathy in hereditary transthyretin amyloidosis: A narrative review
por: Tozza, Stefano, et al.
Publicado: (2021) -
Vitreous amyloidosis caused by a Lys55Asn variant in transthyretin: A case report
por: Tan, Yue, et al.
Publicado: (2022)